Ai Mediq is the first in the world to develop

  1. New modality, that allows to reduce the intensity of hypoxic load without compromising the treatment efficacy – the IHHT mode
  2. Algorithm for calculation of individual therapeutic dose
  3. New device to facilitate the interval hypoxic therapy method involving the biological feed-back with automatic calculation of individual treatment hypoxia dose
  4. Way to dose hypoxic load based on response of human body to the inhale of gaseous mixture with reduced oxygen

ReOxy® is unique as the only device for Hypoxic Treatment approved by as a medical device for professional use by healthcare facilities in cardiac patients

Ai Mediq is a global pioneer in non-pharmacological hypoxia-management treatment method implementation in different directions of medicine